Conformational transitions in glycogen phosphorylase reported by covalently bound pyridoxamine derivatives.
D000249:Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D004355:Drug Stability; D006003:Glycogen / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D046911:Macromolecular Substances; D008956:Models, Chemical; D009132:Muscles / Q000201:enzymology*; D063065:Organophosphonates / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000378:metabolism; D010084:Oxidation-Reduction; D006005:Phosphorylases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D011732:Pyridoxal Phosphate / Q000378:metabolism; D011733:Pyridoxamine / Q000378:metabolism*; D011817:Rabbits; D012542:Scattering, Radiation; D013050:Spectrometry, Fluorescence; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship
D046911:Macromolecular Substances; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000249:Adenosine Monophosphate; D011732:Pyridoxal Phosphate; D011733:Pyridoxamine; D006003:Glycogen; D006005:Phosphorylases